Raymond James & Associates Gsk PLC Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $4.02 Million - $4.57 Million	95,674 Added 6.8%	1,501,654 $65.4 Million
Q1 2022 May 11, 2022	BUY	$40.23 - $47.74 $1.93 Million - $2.29 Million	48,058 Added 3.54%	1,405,980 $61.2 Million
Q4 2021 Feb 08, 2022	SELL	$38.88 - $45.31 $962,824 - $1.12 Million	-24,764 Reduced 1.79%	1,357,922 $59.9 Million
Q3 2021 Nov 02, 2021	SELL	$38.79 - $43.16 $1.77 Million - $1.97 Million	-45,755 Reduced 3.2%	1,382,686 $52.8 Million
Q2 2021 Aug 11, 2021	BUY	$36.52 - $41.46 $2.23 Million - $2.53 Million	61,057 Added 4.47%	1,428,441 $56.9 Million
Q1 2021 May 14, 2021	SELL	$34.27 - $40.01 $5.29 Million - $6.17 Million	-154,319 Reduced 10.14%	1,367,384 $48.8 Million
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $37.1 Million - $43.5 Million	-1,089,534 Reduced 41.72%	1,521,703 $56 Million
Q3 2020 Nov 04, 2020	SELL	$38.11 - $42.99 $10.8 Million - $12.2 Million	-283,680 Reduced 9.8%	2,611,237 $98.3 Million
Q2 2020 Jul 28, 2020	SELL	$37.87 - $43.58 $14 Million - $16.1 Million	-369,722 Reduced 11.33%	2,894,917 $118 Million
Q1 2020 Apr 21, 2020	SELL	$32.47 - $48.83 $8.11 Million - $12.2 Million	-249,645 Reduced 7.1%	3,264,639 $124 Million
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $3.39 Million - $3.89 Million	80,639 Added 2.35%	3,514,284 $165 Million
Q3 2019 Nov 07, 2019	SELL	$40.46 - $43.52 $7.09 Million - $7.63 Million	-175,331 Reduced 4.86%	3,433,645 $147 Million
Q2 2019 Aug 06, 2019	SELL	$39.4 - $42.7 $3.83 Million - $4.15 Million	-97,124 Reduced 2.62%	3,608,976 $144 Million
Q1 2019 May 06, 2019	SELL	$38.57 - $42.69 $2.99 Million - $3.31 Million	-77,506 Reduced 2.05%	3,706,100 $155 Million
Q4 2018 Feb 11, 2019	SELL	$37.8 - $42.69 $13.1 Million - $14.8 Million	-345,517 Reduced 8.37%	3,783,606 $145 Million
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $2.79 Million - $2.99 Million	-70,067 Reduced 1.67%	4,129,123 $166 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $5.51 Million - $5.95 Million	-139,036 Reduced 3.2%	4,199,190 $169 Million
Q1 2018 May 14, 2018	BUY	$36.18 - $40.15 $14.8 Million - $16.5 Million	410,173 Added 10.44%	4,338,226 $169 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $12.3 Million - $14.6 Million	-347,951 Reduced 8.14%	3,928,053 $139 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $28.1 Million - $29.6 Million	713,173 Added 20.02%	4,276,004 $174 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,562,831	3,562,831 $154 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account